ReviewClinical & translational immunology2019

Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma.

Michael P Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.